site stats

Thilo schroeder nextech investment contact

Web11 Oct 2024 · As part of the financing, Thilo Schroeder, PhD, Partner at Nextech Invest, and Kanishka Pothula, Managing Director at BVF Partners, L.P., joined Exo’s Board of Directors. WebNextech Invest is excited to back this amazing team and provocative new venture Thilo Schroeder on LinkedIn: With $520 million in hand, two entrepreneurs try to upend the biotech… Skip to main ...

Thilo Schroeder Net Worth, Biography, and Insider Trading

WebThilo Schroeder is Managing Partner at NEXTECH INVEST Ltd. See Thilo Schroeder's compensation, career history, education, & memberships. WebThilo Schroeder's Email. s****[email protected] Zürich Area, Switzerland. Partner @ Nextech Invest Ltd.. Observer of the Board of Directors @ Peloton Therapeutics. Member … measuring units of storage capacity https://lutzlandsurveying.com

Thilo Schroeder, NEXTECH INVEST Ltd: Profile and …

WebAlfred Scheidegger. Age : 65. Public asset : 9,813 USD. Linked companies : Dottikon Es Holding AG. Summary. Founder of Nextech Invest AG, Alfred Scheidegger currently holds the position of Chairman of The Genetics Co., Inc. and Partner at Nextech Invest AG, Chairman at Nextech Holding AG (a subsidiary of Nextech Invest AG). Dr. Web11 Mar 2024 · Along with the financing, Jonathan Root, M.D., general partner at USVP, and Thilo Schroeder, Ph.D., partner at Nextech Invest Ltd., have joined the board of directors. Existing investors participating in the financing include OrbiMed Advisors LLC, Bristol-Meyers Squibb and Alexandria Venture Investments, LLC. Web30 Nov 2011 · Schroeder Thilo C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY, CA94063: X: ... Nextech Invest AG is the investment advisor of Nextech V Oncology S.C.S., SICAV-SIF ("Nextech V"). The reporting person is a managing member at Nextech Invest AG and may therefore be deemed to be the beneficial owner of shares … peerage member clue

Circle Pharma adds Peter Svennilson, Dr Thilo Schroeder and Dr …

Category:THILO SCHROEDER, PhD - Atavistik Bio

Tags:Thilo schroeder nextech investment contact

Thilo schroeder nextech investment contact

Thilo Schroeder Ph.D Profile: Contact Information & Network

Web28 Jul 2024 · Thilo Schroeder is a partner at Nextech Invest in Zurich, Switzerland, a venture capital firm with a focus on oncology companies. One prominent venture capitalist in the biotech sector had the following to say about him: “Oncology specialist, young guy, trying to build a fund and make a name for himself. Hard to do any which way, even harder ... WebThilo Schroeder, Ph.D. has a passion for precision medicines in cancer with a focus on identifying first and best-in-class targeted therapies regardless of drug modality. Since …

Thilo schroeder nextech investment contact

Did you know?

WebThilo Schroeder. Partner at Nextech Invest. Location: Zürich Area, Switzerland. Thilo Schroeder, Ph.D. has a passion for precision medicines in cancer with a focus on … Web26 Mar 2012 · Description. Nextech II Oncology is a 2004 vintage venture capital fund managed by Nextech Invest. The fund is located in Zurich, Switzerland and it invested in …

Web11 Mar 2024 · Contact Information Fund Manager Nextech Invest Fund Manager Website www.nextechinvest.com Fund Category Venture Capital Open Date 0000-00-00 Close Date 0000-00-00 Fund Family Nextech Oncology Fund Native Currency USD Fund Manager's Location Bahnhofstrasse 18 8001 Zurich Switzerland +41 044 000 00 00 Fund Domiciles … WebView Thilo Schroeder's business profile as Partner at Nextech Invest. Find Thilo's email address, mobile number, work history, and more.

Web11 Mar 2024 · Thilo's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY, CA, 94063 . Insiders trading at Revolution Medicines Inc Over the last 3 years, insiders at Revolution Medicines Inc have traded over $239,689,710 worth of Revolution Medicines Inc stock and bought 2,721,315 units worth … Web7 Jan 2014 · The oncology-focused investor, Nextech Invest Ltd., led the round, which also included founding investors Third Rock Ventures and Fidelity Biosciences as well as public investors Biotech Value ...

Web17 Mar 2024 · In conjunction with the financing, Peter Svennilson, founder and managing partner of The Column Group, and Thilo Schroeder, Ph.D., partner at Nextech Invest were appointed to the board. John Josey, Ph.D., formerly President and CEO of Peloton Therapeutics, was appointed to the board as Chairman.

WebThilo Schroeder, PhD, is Partner at Nextech Invest a global venture fund focused on investing in oncology companies. Prior to joining Nextech Invest in 2012, Dr. Schroeder … peerage us corporationmeasuring up to the sdgs in the ukWebThilo Schroeder is a Partner at Nextech Invest and has a passion for precision medicines in cancer with a focus on identifying first and best-in-class targeted therapies. Thilo has … peerair proWeb5 Oct 2024 · Thilo Schroeder, PhD of Nextech Invest and Kanishka Pothula of BVF Partners, L.P. join the Exo Board of Directors CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Exo Therapeutics, Inc. , a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced … measuring using a ruler interactiveWebThilo Schroeder. Partner at Nextech Invest. Location: Zürich Area, Switzerland. Thilo Schroeder, Ph.D. has a passion for precision medicines in cancer with a focus on identifying first and best-in-class targeted therapies regardless of drug modality. Since 2012, Thilo has helped grow and shape Nextech as a leading oncology focused venture firm. measuring upvc windowsWebThilo has been a leading investor in several precision medicine oncology companies and is a board member of Revolution Medicines (RVMD), PMV Pharma (PMVP), Circle Pharma, Atavistik Bio, MOMA Therapeutics, Silverback Therapeutics (SBTX), Exo Therapeutics and Alterome Therapeutics. peerages in abeyanceWebThe outlook for investments in oncology companies has improved in both the short and long-term, despite the recent sell-off of publicly listed shares. This is the opinion of Alfred Scheidegger and Thilo Schroeder, respectively chief executive officer and partner of Nextech Invest Ltd (formerly Nextech Venture Ltd), which measuring using a ruler worksheet